Log in
(Ad)
A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

$148.25
-1.02 (-0.68 %)
(As of 01/23/2020 04:05 AM ET)
Today's Range
$146.00
Now: $148.25
$149.18
50-Day Range
$139.55
MA: $144.66
$149.27
52-Week Range
$125.00
Now: $148.25
$150.17
Volume10.30 million shs
Average Volume4.72 million shs
Market Capitalization$390.17 billion
P/E Ratio23.16
Dividend Yield2.55%
Beta0.71
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$81.58 billion
Cash Flow$10.84 per share
Book Value$22.28 per share

Profitability

Net Income$15.30 billion

Miscellaneous

Employees135,100
Outstanding Shares2,631,870,000
Market Cap$390.17 billion
Next Earnings DateN/A
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%?

Wall Street legend Paul Mampilly recently identified this as the stock of the century.

Buying up a handful of shares of this small company now could change your life and even make you millions.

Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson declared a quarterly dividend on Thursday, January 2nd. Investors of record on Tuesday, February 25th will be given a dividend of $0.95 per share on Tuesday, March 10th. This represents a $3.80 annualized dividend and a yield of 2.56%. The ex-dividend date is Monday, February 24th. View Johnson & Johnson's Dividend History.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson announced that its board has initiated a share buyback plan on Monday, December 17th 2018, which authorizes the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 1.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board believes its stock is undervalued.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) issued its earnings results on Wednesday, January, 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.01. The business had revenue of $20.75 billion for the quarter, compared to the consensus estimate of $20.83 billion. Johnson & Johnson had a return on equity of 39.81% and a net margin of 21.09%. The business's revenue was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.97 earnings per share. View Johnson & Johnson's Earnings History.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY20 earnings guidance on Wednesday, January, 22nd. The company provided earnings per share guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus estimate of $9.09. The company issued revenue guidance of +4.5-5.5% yr/yr to $85.8-86.2 billion, compared to the consensus revenue estimate of $85.52 billion.

What price target have analysts set for JNJ?

13 brokers have issued 12 month price objectives for Johnson & Johnson's stock. Their forecasts range from $145.00 to $173.00. On average, they anticipate Johnson & Johnson's stock price to reach $159.45 in the next twelve months. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the consensus analysts' recommendation for Johnson & Johnson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

News articles about JNJ stock have trended negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Johnson & Johnson earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Johnson & Johnson.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 20,870,000 shares, an increase of 21.3% from the November 28th total of 17,210,000 shares. Based on an average trading volume of 7,440,000 shares, the short-interest ratio is presently 2.8 days. Currently, 0.8% of the shares of the company are short sold. View Johnson & Johnson's Current Options Chain.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), Pfizer (PFE), Intel (INTC), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and Home Depot (HD).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the folowing people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Johanson Financial Advisors Inc. (0.09%), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST (0.08%), Manning & Napier Group LLC (0.07%), Marathon Asset Management LLP (0.07%), PGGM Investments (0.05%) and DNB Asset Management AS (0.05%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Hubert Joly, Joaquin Duato, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

Which major investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., PGGM Investments, DNB Asset Management AS, Hexavest Inc., United Services Automobile Association, Commerzbank Aktiengesellschaft FI, Marathon Asset Management LLP and Meag Munich Ergo Kapitalanlagegesellschaft MBH. View Insider Buying and Selling for Johnson & Johnson.

Which major investors are buying Johnson & Johnson stock?

JNJ stock was bought by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Artemis Investment Management LLP, WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST, Hamlin Capital Management LLC, Empire Life Investments Inc., Bristol John W & Co. Inc. NY, Tandem Investment Advisors Inc. and Advisors Capital Management LLC. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince, Hubert Joly and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $148.25.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $390.17 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  901 (Vote Outperform)
Underperform Votes:  968 (Vote Underperform)
Total Votes:  1,869
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: What Are Cryptocurrencies?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel